Ipca Laboratories Ltd
Silodosin (4mg) + Dutasteride (0.5mg)
Rapilif-D 4/0.5 Capsule is a combination medicine used to treat symptoms of an enlarged prostate gland in men.
Capsule
Rapilif-D 4/0.5 Capsule is a combination of two medicines, Silodosin and Dutasteride, that work together to relieve symptoms of benign prostatic hyperplasia (BPH) such as difficulty urinating or frequent urination. It is not intended to prevent prostate cancer. Common side effects may include dizziness, blurring of vision, and sexual dysfunction. It is important to follow the prescribed dosage and consult your doctor for any concerns.
Take this medicine in the dose and duration as advised by your doctor. Rapilif-D 4/0.5 Capsule is to be taken with food, approximately 30 minutes after the same meal each day.
Rapilif-D 4/0.5 Capsule is a combination of Silodosin, an alpha-blocker that relaxes the muscles around the bladder exit and prostate gland to allow easy passage of urine, and Dutasteride, a 5-alpha-reductase inhibitor that helps shrink the prostate gland by decreasing the level of the hormone that promotes its growth.
You have been prescribed Rapilif-D 4/0.5 Capsule to relieve the symptoms of benign prostatic hyperplasia (BPH). Take it approximately 30 minutes after the same meal each day. Rapilif-D 4/0.5 Capsule may cause dizziness or blurring of vision. Do not drive or do anything requiring concentration until you know how it affects you. To lower the chance of feeling dizzy or passing out, rise slowly if you have been sitting or lying down. If you are scheduled to undergo eye surgery due to cataract or glaucoma, inform your eye doctor about the usage of Rapilif-D 4/0.5 Capsule. It may cause difficulty achieving or maintaining an erection (impotence), decreased sex drive, and ejaculation disorders such as decreased amount of semen produced or decreased sperm count. Do not donate blood for 6 months after taking the last dose of Rapilif-D 4/0.5 Capsule.
Rapilif-D 4/0.5 Capsule is effective when used as directed by your doctor. It is essential to take the medication in the recommended dose and duration to achieve the desired results. Stopping the medication too early may lead to a recurrence of symptoms or worsening of the condition.
Benign prostatic hyperplasia (BPH), also known as prostate gland enlargement, is a common condition affecting older men. It can cause symptoms such as frequent or urgent need to urinate, increased frequency of urination at night, and difficulty fully emptying the bladder.
Yes, Rapilif-D 4/0.5 Capsule may cause dizziness (feeling faint, weak, unsteady, or lightheaded) in some patients. This side effect is usually due to the presence of silodosin in the medication. If you experience dizziness, it is recommended to rest for a while and resume taking the medication once you feel better.
Rapilif-D 4/0.5 Capsule is contraindicated in patients who are allergic to any of its active or inactive ingredients. Additionally, caution is advised in patients with underlying kidney or liver disease. If you are unsure about your suitability for this medication, consult your doctor for personalized advice.
Store Rapilif-D 4/0.5 Capsule in its original container, tightly closed, and follow the storage instructions provided on the packaging or label. Dispose of any unused medication properly, ensuring it is not consumed by pets, children, or other individuals.
Rapilif-D 4/0.5 Capsule is generally safe when used as directed by your doctor. To ensure its safety, take the medication exactly as prescribed, do not skip any doses, and follow your doctor's instructions carefully. If you experience any side effects, inform your doctor.
It is recommended to take Rapilif-D 4/0.5 Capsule after meals. Swallow the capsules whole, without chewing or splitting them. Always follow your doctor's advice and do not miss any doses.